Acorah Software Products - Accounts Production 19.2.350 false true 31 March 2025 1 April 2024 false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 14457365 Dr Sreehari Sreekala iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14457365 2025-03-31 14457365 2026-03-31 14457365 2025-04-01 2026-03-31 14457365 frs-core:CurrentFinancialInstruments 2026-03-31 14457365 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14457365 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 14457365 frs-bus:Micro-entities 2025-04-01 2026-03-31 14457365 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 14457365 frs-bus:Director1 2025-04-01 2026-03-31 14457365 frs-bus:Director1 2025-03-31 14457365 frs-bus:Director1 2026-03-31 14457365 2024-03-31 14457365 2025-03-31 14457365 2024-04-01 2025-03-31 14457365 frs-core:CurrentFinancialInstruments 2025-03-31
Registered number: 14457365
Hubble Pathology Services Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Medical Finance Limited
Balance Sheet
Registered number: 14457365
2026 2025
£ £
Fixed assets - 504
Current assets 9,661 13,026
Creditors: Amounts Falling Due Within One Year (3,611 ) (7,717 )
NET CURRENT ASSETS 6,050 5,309
TOTAL ASSETS LESS CURRENT LIABILITIES 6,050 5,813
NET ASSETS 6,050 5,813
CAPITAL AND RESERVES 6,050 5,813

Notes

1. General Information
Hubble Pathology Services Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14457365 . The registered office is 1 Argyle Street, Bath, England, BA2 4BA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: )
- -
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 April 2025 Amounts advanced Amounts repaid Amounts written off As at 31 March 2026
£ £ £ £ £
Dr Sreehari Sreekala (2,028 ) (7,207 ) 10,634 - 1,399
The director's loan amount of £1,399 due from Dr Sreehari Sreekala to the company is expected to be repaid within nine months of the year end.
Page 0
Page 1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Sreehari Sreekala
Director
24/06/2026